Eli Lilly’s lebrikizumab significantly improves atopic dermatitis in Phase III trial
August 16, 2021Sales and Marketing
Eli Lilly’s lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic dermatitis in two Phase III trials. …
Health Canada accepts rolling submission for Merck’s experimental COVID therapy
August 16, 2021Sales and Marketing
Merck has begun its rolling submission to Health Canada for its experimental antiviral agent, molnupiravir, as a potential COVID-19 therapy. …
Australia buys Pfizer vaccines from Poland amid record COVID infections
August 16, 2021Sales and Marketing
Australia has purchased around 1 million Pfizer vaccines from Poland as the country battles a wave of infections. Australian Prime …
President Joe Biden calls for lower prescription drug costs
August 13, 2021Medical Communications
President Joe Biden has called on congress to take steps to lower prescription drug costs. This would also include allowing …
$14.4 million: UnitedHealth Group settles charges of illegally denying coverage to patients
August 13, 2021Medical Communications
The largest US health insurer, UnitedHealth Group, has settles federal and New York state charges of illegally denying coverage to …
FDA authorises third shot of Pfizer or Moderna for immunocompromised
August 13, 2021Medical Communications
The FDA has authorised a third shot of the Pfizer or Moderna COVID-19 vaccine for some people with weakened immune …
CMA to investigate travel PCR test companies over alleged pricing misconduct
August 13, 2021Medical Communications
Britain’s competition watchdog, the Competition and Markets Authority (CMA), has announced that it will help the government take action against …
FDA approves new indication for chronic sleep disorder
August 13, 2021Medical Communications
The FDA has approved a new indication for Xywav for idiopathic hypersomnia (IH) in adults. IH is an uncommon chronic …
US Veterans Health Administration rejects Biogen Alzheimer’s drug
August 12, 2021The US Veterans Health Administration (VHA) has turned down Biogen’s Alzheimer’s drug, Aduhelm (aducanumab), opting not to include the $56,000-a-year …
AstraZeneca vaccine age restrictions has ended reports of rare clots
August 12, 2021After the UK’s decision to restrict the use of AstraZeneca’s vaccine in under 40s there have been no new cases …
WHO to launch trial investigating anti-inflammatory drugs for COVID patients
August 12, 2021The World Health Organization (WHO) announced on Wednesday that a clinical trial is to begin to study three anti-inflammatory drugs …
EMA investigating Pfizer and Moderna vaccine side effects
August 12, 2021The EMA has launched an investigation into the Pfizer and Moderna vaccines after three new conditions have been reported as …
NICE approves Eli Lilly’s abemaciclib for advanced breast cancer
August 12, 2021NICE has approved Eli Lilly’s abemaciclib, given with fulvestrant, for hormone receptor-positive HER2-negative breast cancer which has spread to other …
Cannabidiol gains MHRA approval as adjunctive treatment of seizures
August 11, 2021Research and Development
GW Pharmaceuticals has announced that is has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for …
Janssen’s MS treatment Ponvory is granted UK marketing authorisation
August 11, 2021Research and Development
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted Marketing Authorisation in Great Britain for PONVORY (ponesimod) for the …
Sputnik V vaccine 13% less effective against Delta than originally reported
August 11, 2021Medical Communications, Research and Development
Russian health officials have announced that the Sputnik V COVID vaccine is 83% effective against the Delta variant on Wednesday, …
More than 75% of UK adults have been double jabbed
August 11, 2021Research and Development
More than 75% of adults living in the UK have now received both doses of the vaccine, as announced by …
Moderna and Canada to collaborate on mRNA manufacturing
August 11, 2021Manufacturing and Production, Research and Development
Moderna will build a messenger RNA (mRNA) vaccine manufacturing facility in Canada, which will include access to Moderna’s mRNA development …
Kite receives positive recommendation from SMC for CAR T therapy
August 10, 2021Manufacturing and Production, Research and Development
Kite has announced a positive recommendation from the Scottish Medicines Consortium (SMC) on the company’s Healthcare Technology Assessment for Tecartus, …
Researchers develop injectable hydrogel to combat Parkinson’s
August 10, 2021Medical Communications, Research and Development
An Australian research team has developed a hydrogel that can be used as a one-off intervention to treat Parkinson’s disease, …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
